Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Wellstar Launches Thermal Imaging System

Wellstar International, Inc. announced that its subsidiary, Trillennium Medical Imaging is ready to begin marketing of thermal imaging system to long-term care facilities in US. TMI's thermal imaging diagnostic device has the ability to objectively identify patterns of injury associated with the development of pressure ulcers. This early detection leads to intervention and even prevention. A patient receives considerably better care by avoiding a pressure ulcer occurrence altogether by identifying the tissue changes associated with the development of these wounds prior to skin breakdown. They receive a higher rating in the pay for performance initiative from the Centers for Medicare & Medicaid Services when long-term care facilities reduce the occurrence of pressure ulcers within their facility. The device utilizes TMI's thermal imaging system technology that provides better overall patient care by significantly lowering their pressure ulcer incident rate. LTC facility also curtails its liabilities by protecting itself against costly lawsuits by having complete documentation of every skin assessment performed. TMI's marketing plan includes a program where LTC facilities can lease the equipment necessary to perform skin assessments and store the necessary data onsite. The Company anticipates placing initial units within these facilities sometime within the first quarter of 2009. Thermal imaging system has been developed for various applications. The TMI technology and software has been approved by the FDA as an Adjunctive Diagnostic Screening Procedure for early breast cancer detection, differential diagnoses of pain dysfunctions (such as Reflex Sympathetic Dystrophy, Neuromuscular Skeletal Syndromes and neurological disorders), for the early detection of pressure ulcers, deep tissue injuries and bedsores, as well as for orthopedic applications. The company has plans to market diagnostic systems for all of the above mentioned applications.